According to Khairy, Malaysia will stick with AstraZeneca.

PUTRAJAYA: According to National Covid-19 Immunisation Programme coordinating minister Khairy Jamaluddin, Malaysia will continue with the purchasing of AstraZeneca Covid-19 vaccines because there is no proof that the vaccine triggers blood clots.

He said that AstraZeneca had told Malaysia about the vaccine’s side effects, and that no evidence has been found to link the vaccine to cases of blood clots in people, which have resulted in deaths in a few countries.

Related Posts

“As of now, we will stick by our stand. The purchase of the AstraZeneca vaccines remains,” he told a joint press conference with health minister Dr Adham Baba on the development of the immunisation programme today.

Following reports of blood clots occurring in some people after being vaccinated, several nations, including Denmark, Norway, Iceland, and Thailand, have reportedly halted the roll-out of AstraZeneca’s vaccine. Several batches of the vaccine have also been discontinued in Italy and Austria.

Khairy, the minister of science, technology, and innovation, confirmed that the ministry would review clinical evidence from foreign events in order for experts to draw conclusions regarding vaccine use.

The National Pharmaceutical Regulatory Division (NPRA), according to Adham, performs extensive research on any vaccine that is to be used in Malaysia.

“We trust the NPRA’s decisions, and in the case of the AstraZeneca vaccine, we have looked into its quality and safety,” he said.

The conditional registration of AstraZeneca’s Covid-19 vaccine was approved by the Drug Control Authority on March 2.

In another matter, Khairy claimed that for the first phase of the immunisation program, Malaysia will receive additional Pfizer-BioNTech vaccines in stages.

He said that 83,070 doses of the Pfizer-BioNTech vaccine were shipped today, with another 124,020 doses arriving on March 22 and another 125,190 doses arriving on March 26.

“Cumulatively, Malaysia will receive 1,000,350 doses of vaccine and this completes the delivery for the first quarter,” he said, adding that 100,000 doses of Sinovac vaccine were also delivered today.

When asked why Malaysia purchased large quantities of Covid-19 vaccines, Khairy clarified that the bulk procurement was made to assist with the mitigation process, which includes reducing the possibility of vaccine delivery delays to Malaysia.

Katherine S

1/4 German, 3/4 Malaysian. I write, follow and monitor closely political news happening in Malaysia, and other happening news in the ASEAN region. Newswriter for the best ASEAN news website - The Asian Affairs.

Recent Posts

Box Office Battle: Singham Again and Bhool Bhulaiyaa 3 Set for Epic Diwali Clash

Two big banner movies of Bollywood are preparing for a festive season box office battle as ‘Singham Again’ starring Ajay…

November 1, 2024

Apple Launches MacBook Pro with Revolutionary M4 Chip Family, Starting at ₹1.69 Lakh in India

The new MacBook Pro series takes Apple’s premium laptop offering to the next level, thanks to the new M4 family…

October 31, 2024

North Korea’s New ICBM Launch: An Assertive Display of Strength Amid Global Tensions

With a record-setting intercontinental ballistic missile (ICBM) test, North Korea boldly claimed it as the "world's most powerful strategic deterrent."…

October 31, 2024

Record Snow Delay Leaves Japan’s Mount Fuji Bare in October: Climate Change Alters Iconic Landscape

Late October's bare Mount Fuji, a symbol of resiliency and natural beauty, marks the first time in 130 years that…

October 31, 2024

Understanding Why Children Lie: A Guide for Parents

Children eventually learn to see that others cannot read their thoughts as they negotiate their developmental path. Research on an…

October 31, 2024

Netflix Releases ‘Moments’ Feature to Boost Clip Sharing as Part of New Brand Campaign

With a new tool dubbed "Moments," Netflix is improving users' experience and sharing of their preferred scenes. Although the behemoth…

October 31, 2024

This website uses cookies.

Read More